In normal cells, brief activation of NRF2, as a response to elevated ROS levels, acts as a cytoprotective, anticancer mechanism, as it reduces possible harm that might occur due to oxidative stress, which subsequently could lead to tumor initiation and progression [8,9]. Here, NFE2L2 is linked to neoplasm.